NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
22,749,558
Share change
+3,166,660
Total reported value
$258,733,000
Put/Call ratio
25%
Price per share
$11.38
Number of holders
60
Value change
+$35,271,764
Number of buys
36
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q1 2020

As of 31 Mar 2020, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,749,558 shares. The largest 10 holders included Redmile Group, LLC, EcoR1 Capital, LLC, BAKER BROS. ADVISORS LP, Opaleye Management Inc., BOXER CAPITAL, LLC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Fairmount Funds Management LLC, MILLENNIUM MANAGEMENT LLC, and PICTET ASSET MANAGEMENT LTD. This page lists 60 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.